ANDA 89744, held by Hospira. Phenytoin Sodium.
As of Nov 16, 2026, ANDA 89744 (Phenytoin Sodium), held by Hospira, was first approved by FDA on Dec 18, 1987, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 18, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Phenytoin Sodium50MG/ML ยท injectable;injection | Phenytoin Sodium | Discontinued |
| Jan 29, 2014 | Supplement 16Labeling | Approved | None posted |
| Feb 14, 2001 | Supplement 8Manufacturing | Approved | None posted |
| Mar 25, 1998 | Supplement 7Labeling | Approved | None posted |
| Dec 22, 1995 | Supplement 6Manufacturing | Approved | None posted |
| Oct 8, 1993 | Supplement 5Manufacturing | Approved | None posted |
| Oct 28, 1991 | Supplement 3Labeling | Approved | None posted |
| Mar 1, 1990 | Supplement 2Manufacturing | Approved | None posted |
| Jul 6, 1989 | Supplement 1Manufacturing | Approved | None posted |
| Dec 18, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters